Loading provider…
Loading provider…
Nephrology Physician in San Francisco, CA
NPI: 1417974247Primary Practice Location
Cpmc Pacific Heights Outpatient Campus
2333 Buchanan St, San Francisco, CA
Primary Employer
Sutter Pacific Medical Foundation
sutterhealth.org
HQ Phone
Get MD Venkat's Phone Numberphone_androidMobile
Get MD Venkat's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2003 - 2027
OH State Medical License
1995 - 2004
PA State Medical License
2001 - 2004

American Board of Internal Medicine
Nephrology
University of Cincinnati Medical Center/College of Medicine
Fellowship • Nephrology
1993 - 1995
Gandhi Medical College
Medical School
Until 1986
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 154 | 174 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 70 | 212 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 51 | 62 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 36 | 41 |
Authors: Michael Abecassis, John Friedewald, Roslyn Mannon, James Rice, Richard Knight, Christopher Marsh, Didier Mandelbrot, Daniel Maluf
Journal: Transplant Proc
Publication Date: 2018-12-11
Incidental diagnosis of gastric cancer in transplant recipients improves patient survival
Authors: Joseph Buell
Journal: Surgery
Impact of ganciclovir prophylaxis on cytomegalovirus infection in recipients of cadaveric renal allografts.
Authors: V. Ram Peddi, S. Hariharan, Timothy J. Schroeder, First Mr
Publication Date: 1997-01
Lead Sponsor: Hansa Biopharma AB
Intervention / Treatment: DRUG: Eculizumab, PROCEDURE: PLEX, OTHER: Remain on wait list, DRUG: IVIg, DRUG: Imlifidase, DRUG: Anti-CD20 antibodies
Lead Sponsor: California Pacific Medical Center Research Institute
Collaborators: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: sirolimus
Lead Sponsor: Alexion Pharmaceuticals, Inc.
Collaborators: CTI Clinical Trial and Consulting Services
Intervention / Treatment: DRUG: Placebo, DRUG: Eculizumab